Prognostic Value of Combined Detection of Preoperative Albumin-to-Fibrinogen Ratio and Neutrophil-to-Lymphocyte Ratio in Operable Esophageal Squamous Cell Carcinoma Patients without Neoadjuvant Therapy

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Yang CS, Chen X, Tu S. Etiology and prevention of esophageal cancer. Gastrointest Tumors. 2016;3(1):3–16. doi:10.1159/00044315527722152
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow. Lancet. 2001;357(9255):539–545. doi:10.1016/S0140-6736(00)04046-011229684
   PubMed Web of Science ®Google Scholar
• Alifano M, Mansuet-Lupo A, Lococo F, et al. Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer. PLoS One. 2014;9(9):e106914. doi:10.1371/journal.pone.010691425238252
   PubMed Web of Science ®Google Scholar
• Perisanidis C, Psyrri A, Cohen EE, et al. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41(10):960–970. doi:10.1016/j.ctrv.2015.10.00226604093
   PubMed Web of Science ®Google Scholar
• Lindenmann J, Fink-Neuboeck N, Koesslbacher M, et al. The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment. J Surg Oncol. 2014;110(6):645–650. doi:10.1002/jso.2371124975677
   PubMed Web of Science ®Google Scholar
• Matsuda S, Takeuchi H, Kawakubo H, et al. Prognostic impact of change in the fibrinogen and albumin score during preoperative treatment in esophageal cancer patients. World J Surg. 2017;41(11):2788–2795. doi:10.1007/s00268-017-4074-828608015
   PubMed Web of Science ®Google Scholar
• Muroya T, Wajima N, Ogasawara H, et al. [The impact of neutrophil-lymphocyte ratio on the prognosis in patients who underwent esophagectomy for esophageal cancer]. Gan to Kagaku Ryoho. 2017;44(10):912–914. Japanese.29066693
   PubMedGoogle Scholar
• Yodying H, Matsuda A, Miyashita M, et al. Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2016;23(2):646–654. doi:10.1245/s10434-015-4869-526416715
   PubMed Web of Science ®Google Scholar
• Regueiro M, Kip KE, Cheung O, Hegazi RA, Plevy S. Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(1):42–47. doi:10.1097/00054725-200501000-0000615674112
   PubMed Web of Science ®Google Scholar
• Farrell GC, Chitturi S, Lau GK, Sollano JD; Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 2007;22(6):775–777. doi:10.1111/j.1440-1746.2007.05002.x17565629
   PubMed Web of Science ®Google Scholar
• Donohoe CL, Phillips AW. Cancer of the esophagus and esophagogastric junction: an 8th edition staging primer. J Thorac Dis. 2017;9(3):E282–E284. doi:10.21037/jtd.2017.03.3928449521
   PubMed Web of Science ®Google Scholar
• Hamanaka K, Miura K, Koyama T, et al. The pretreatment circulating albumin-to-fibrinogen ratio in patients with non-small cell lung cancer: a simple, economical, and effective biomarker. J Thorac Dis. 2019;11(Suppl 3):S241–S244. doi:10.21037/jtd.2019.01.8330997187
   PubMed Web of Science ®Google Scholar
• Guo J, Chen S, Chen Y, Li S, Xu D. Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer. Cancer Manag Res. 2018;10:315–321. doi:10.2147/CMAR.S15607129491721
   PubMed Web of Science ®Google Scholar
• Templeton AJ, Ace O, McNamara MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23(7):1204–1212. doi:10.1158/1055-9965.EPI-14-014624793958
   PubMed Web of Science ®Google Scholar
• Huang Y, Feng JF. Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther. 2015;8:137–145. doi:10.2147/OTT.S7379425609981
   PubMed Web of Science ®Google Scholar
• Gao ZM, Wang RY, Deng P, et al. TNM-PNI: a novel prognostic scoring system for patients with gastric cancer and curative D2 resection. Cancer Manag Res. 2018;10:2925–2933. doi:10.2147/CMAR.S16920630214287
   PubMed Web of Science ®Google Scholar
• Wuhao H, Shengguang W, Hua Z, Bin Z, Changli W. Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer. Cancer Biol Med. 2018;15(1):88–96. doi:10.20892/j.issn.2095-3941.2017.012429545972
   PubMed Web of Science ®Google Scholar
• Silva TH, Schilithz A, Peres W, Murad LB. Neutrophil-lymphocyte ratio and nutritional status are clinically useful in predicting prognosis in colorectal cancer patients. Nutr Cancer. 2020;72(8):1345–1354. doi:10.1080/01635581.2019.167919831665931
   PubMed Web of Science ®Google Scholar
• McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008;67(3):257–262. doi:10.1017/S002966510800713118452641
   PubMed Web of Science ®Google Scholar
• Xue Y, Zhou X, Xue L, Zhou R, Luo J. The role of pretreatment prognostic nutritional index in esophageal cancer: a meta-analysis. J Cell Physiol. 2019;234(11):19655–19662. doi:10.1002/jcp.2856531344989
   PubMed Web of Science ®Google Scholar
• Matsuda S, Takeuchi H, Kawakubo H, et al. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score. Ann Surg Oncol. 2015;22(1):302–310. doi:10.1245/s10434-014-3857-524952029
   PubMed Web of Science ®Google Scholar
• Agarwal S, Graepel T, Herbrich R, Har-Peled S, Roth D, Jordan MI. Generalization bounds for the area under the ROC curve. J Mach Learn Res. 2005;6(2):393–425.
   Google Scholar
• Martínez-Camblor P, Carleos C, Corral N. Powerful nonparametric statistics to compare k independent ROC curves. J Appl Stat. 2011;38(7):1317–1332.
   Web of Science ®Google Scholar
• Gao QF, Qiu JC, Huang XH, et al. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy. Cancer Cell Int. 2018;18:153. doi:10.1186/s12935-018-0648-230305803
   PubMed Web of Science ®Google Scholar
• Huang YQ, Liang CH, He L, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157–2164. doi:10.1200/JCO.2015.65.912827138577
   PubMed Web of Science ®Google Scholar
• Li XH, Chang H, Xu BQ, et al. An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study. Cancer Med. 2017;6(1):310–319. doi:10.1002/cam4.94727860387
   PubMed Web of Science ®Google Scholar
• Hilden J. Commentary: on NRI, IDI, and “good-looking” statistics with nothing underneath. Epidemiology. 2014;252):265–267. doi:10.1097/EDE.000000000000006324487208
   PubMed Web of Science ®Google Scholar
• Burch PM, Glaab WE, Holder DJ, Phillips JA, Sauer JM, Walker EG. Net reclassification index and integrated discrimination index are not appropriate for testing whether a biomarker improves predictive performance. Toxicol Sci. 2017;156(1):11–13. doi:10.1093/toxsci/kfw22527815493
   PubMed Web of Science ®Google Scholar
• Van Oirbeek R, Lesaffre E. An application of Harrell’s C-index to PH frailty models. Stat Med. 2010;29(30):3160–3171. doi:10.1002/sim.405821170910
   PubMed Web of Science ®Google Scholar
• Wan G, Gao F, Chen J, et al. Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma. BMC Cancer. 2017;17(1):91. doi:10.1186/s12885-017-3062-628143427
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8:53. doi:10.1186/1472-6947-8-5319036144
   PubMed Web of Science ®Google Scholar
• Van Calster B, Vickers AJ. Calibration of risk prediction models: impact on decision-analytic performance. Med Decis Making. 2015;35(2):162–169. doi:10.1177/0272989X1454723325155798
   PubMed Web of Science ®Google Scholar